Serveur d'exploration Hippolyte Bernheim

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

Histiocytic lymphoma cell lines: Immunologic and cytogenetic studies

Identifieur interne : 000874 ( Istex/Corpus ); précédent : 000873; suivant : 000875

Histiocytic lymphoma cell lines: Immunologic and cytogenetic studies

Auteurs : Barbara Kaiser-Mccaw Hecht ; Alan L. Epstein ; Carol S. Berger ; Henry S. Kaplan ; Frederick Hecht

Source :

RBID : ISTEX:6473D2AA67B2D7B908E7412174A4A224DBE56489

English descriptors

Abstract

Abstract: Cell lines were established from 15 patients with diffuse histiocytic lymphoma (DHL) of the intermediate grade, diffuse large cell (class G), and high-grade, large cell immunoblastic (class H) types. Immunologic studies indicated that 11 of the 15 DHL cell lines were B cell in origin, 2 were histiocytic, and 2 were null cell. Cytogenetic studies revealed 1 hypodiploid, 11 hyperdiploid, and 3 near-tetraploid cell lines. Chromosome #7 was trisomic in 3 lines, chromosomes #12 in 4 lines, and chromosome #13 in 3 lines. Chromosome #2 was monosomic in 3 lines, chromosome #8 was monosomic in 5 lines, chromosome #14 in 4 lines, and chromosome #22 in 6 cell lines. This is of special interest, as chromosomes #2, #8, #14, and #22 are clearly concerned with rearrangements in Burkitt's lymphoma and immunoglobulin expression. The most common rearrangement in the DHL cell lines involved chromosome #14 at band 14q32. However, in contrast to Burkitt's lymphoma, the pattern of translocation in DHL is between chromosome #14 and usually chromosome #11 or chromosome #18. The 14;18 translocation is not restricted to patients with low-grade follicular, small cleaved cell lymphomas, as has been reported. The 14q+ chromosome is characteristic of lymphoid malignancies in general. It is due, invariably, to a translocation with the breakpoint in band 14q32, which is the locus of the immunoglobulin heavy chain genes. We propose that in each translocation, for example, chromosomes #11 or #18, an oncogene may be transposed onto chromosome #14, and that each 14q+ translocation in DHL represents an event that transposes an oncogene from another chromosome to chromosome #14.

Url:
DOI: 10.1016/0165-4608(85)90186-4

Links to Exploration step

ISTEX:6473D2AA67B2D7B908E7412174A4A224DBE56489

Le document en format XML

<record>
<TEI wicri:istexFullTextTei="biblStruct">
<teiHeader>
<fileDesc>
<titleStmt>
<title>Histiocytic lymphoma cell lines: Immunologic and cytogenetic studies</title>
<author>
<name sortKey="Hecht, Barbara Kaiser Mccaw" sort="Hecht, Barbara Kaiser Mccaw" uniqKey="Hecht B" first="Barbara Kaiser-Mccaw" last="Hecht">Barbara Kaiser-Mccaw Hecht</name>
<affiliation>
<mods:affiliation>Genetics Center and Cancer Research Center, Southwest Biomedical Research Institute, Tempe, AZ, USA</mods:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Epstein, Alan L" sort="Epstein, Alan L" uniqKey="Epstein A" first="Alan L." last="Epstein">Alan L. Epstein</name>
<affiliation>
<mods:affiliation>Department of Medicine, Northwestern University, Chicago, IL, USA</mods:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Berger, Carol S" sort="Berger, Carol S" uniqKey="Berger C" first="Carol S." last="Berger">Carol S. Berger</name>
<affiliation>
<mods:affiliation>Genetics Center and Cancer Research Center, Southwest Biomedical Research Institute, Tempe, AZ, USA</mods:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Kaplan, Henry S" sort="Kaplan, Henry S" uniqKey="Kaplan H" first="Henry S." last="Kaplan">Henry S. Kaplan</name>
<affiliation>
<mods:affiliation>Cancer Biology Research Laboratory, Stanford University School of Medicine, Stanford, CA, USA</mods:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Hecht, Frederick" sort="Hecht, Frederick" uniqKey="Hecht F" first="Frederick" last="Hecht">Frederick Hecht</name>
<affiliation>
<mods:affiliation>Genetics Center and Cancer Research Center, Southwest Biomedical Research Institute, Tempe, AZ, USA</mods:affiliation>
</affiliation>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">ISTEX</idno>
<idno type="RBID">ISTEX:6473D2AA67B2D7B908E7412174A4A224DBE56489</idno>
<date when="1984" year="1984">1984</date>
<idno type="doi">10.1016/0165-4608(85)90186-4</idno>
<idno type="url">https://api.istex.fr/document/6473D2AA67B2D7B908E7412174A4A224DBE56489/fulltext/pdf</idno>
<idno type="wicri:Area/Istex/Corpus">000874</idno>
<idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Corpus" wicri:corpus="ISTEX">000874</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title level="a">Histiocytic lymphoma cell lines: Immunologic and cytogenetic studies</title>
<author>
<name sortKey="Hecht, Barbara Kaiser Mccaw" sort="Hecht, Barbara Kaiser Mccaw" uniqKey="Hecht B" first="Barbara Kaiser-Mccaw" last="Hecht">Barbara Kaiser-Mccaw Hecht</name>
<affiliation>
<mods:affiliation>Genetics Center and Cancer Research Center, Southwest Biomedical Research Institute, Tempe, AZ, USA</mods:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Epstein, Alan L" sort="Epstein, Alan L" uniqKey="Epstein A" first="Alan L." last="Epstein">Alan L. Epstein</name>
<affiliation>
<mods:affiliation>Department of Medicine, Northwestern University, Chicago, IL, USA</mods:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Berger, Carol S" sort="Berger, Carol S" uniqKey="Berger C" first="Carol S." last="Berger">Carol S. Berger</name>
<affiliation>
<mods:affiliation>Genetics Center and Cancer Research Center, Southwest Biomedical Research Institute, Tempe, AZ, USA</mods:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Kaplan, Henry S" sort="Kaplan, Henry S" uniqKey="Kaplan H" first="Henry S." last="Kaplan">Henry S. Kaplan</name>
<affiliation>
<mods:affiliation>Cancer Biology Research Laboratory, Stanford University School of Medicine, Stanford, CA, USA</mods:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Hecht, Frederick" sort="Hecht, Frederick" uniqKey="Hecht F" first="Frederick" last="Hecht">Frederick Hecht</name>
<affiliation>
<mods:affiliation>Genetics Center and Cancer Research Center, Southwest Biomedical Research Institute, Tempe, AZ, USA</mods:affiliation>
</affiliation>
</author>
</analytic>
<monogr></monogr>
<series>
<title level="j">Cancer Genetics and Cytogenetics</title>
<title level="j" type="abbrev">CGC</title>
<idno type="ISSN">0165-4608</idno>
<imprint>
<publisher>ELSEVIER</publisher>
<date type="published" when="1984">1984</date>
<biblScope unit="volume">14</biblScope>
<biblScope unit="issue">3–4</biblScope>
<biblScope unit="page" from="205">205</biblScope>
<biblScope unit="page" to="218">218</biblScope>
</imprint>
<idno type="ISSN">0165-4608</idno>
</series>
</biblStruct>
</sourceDesc>
<seriesStmt>
<idno type="ISSN">0165-4608</idno>
</seriesStmt>
</fileDesc>
<profileDesc>
<textClass>
<keywords scheme="Teeft" xml:lang="en">
<term>Abnormality</term>
<term>Biomedical research institute</term>
<term>Cell line</term>
<term>Cell lines</term>
<term>Cell lymphomas</term>
<term>Cell type</term>
<term>Chain genes</term>
<term>Chromosomal</term>
<term>Chromosome</term>
<term>Cytogenetic</term>
<term>Cytogenetic studies</term>
<term>Diffuse</term>
<term>Diffuse histiocytic</term>
<term>Epstein</term>
<term>Hecht</term>
<term>Histiocytic</term>
<term>Histiocytic lymphoma cell lines</term>
<term>Human chromosomes</term>
<term>Human immunoglobulin</term>
<term>Immunoglobulin</term>
<term>Intermediate grade</term>
<term>Kaplan</term>
<term>Karyotype</term>
<term>Large cell</term>
<term>Large cell immunoblastic</term>
<term>Leukemia</term>
<term>Lymphocytic</term>
<term>Lymphoma</term>
<term>Lymphoma cell lines</term>
<term>Malignant</term>
<term>Malignant lymphoma</term>
<term>Malignant lymphomas</term>
<term>Marker chromosome</term>
<term>Null cell</term>
<term>Oncogene</term>
<term>Proc natl acad</term>
<term>Rearrangement</term>
<term>Translocation</term>
</keywords>
</textClass>
<langUsage>
<language ident="en">en</language>
</langUsage>
</profileDesc>
</teiHeader>
<front>
<div type="abstract" xml:lang="en">Abstract: Cell lines were established from 15 patients with diffuse histiocytic lymphoma (DHL) of the intermediate grade, diffuse large cell (class G), and high-grade, large cell immunoblastic (class H) types. Immunologic studies indicated that 11 of the 15 DHL cell lines were B cell in origin, 2 were histiocytic, and 2 were null cell. Cytogenetic studies revealed 1 hypodiploid, 11 hyperdiploid, and 3 near-tetraploid cell lines. Chromosome #7 was trisomic in 3 lines, chromosomes #12 in 4 lines, and chromosome #13 in 3 lines. Chromosome #2 was monosomic in 3 lines, chromosome #8 was monosomic in 5 lines, chromosome #14 in 4 lines, and chromosome #22 in 6 cell lines. This is of special interest, as chromosomes #2, #8, #14, and #22 are clearly concerned with rearrangements in Burkitt's lymphoma and immunoglobulin expression. The most common rearrangement in the DHL cell lines involved chromosome #14 at band 14q32. However, in contrast to Burkitt's lymphoma, the pattern of translocation in DHL is between chromosome #14 and usually chromosome #11 or chromosome #18. The 14;18 translocation is not restricted to patients with low-grade follicular, small cleaved cell lymphomas, as has been reported. The 14q+ chromosome is characteristic of lymphoid malignancies in general. It is due, invariably, to a translocation with the breakpoint in band 14q32, which is the locus of the immunoglobulin heavy chain genes. We propose that in each translocation, for example, chromosomes #11 or #18, an oncogene may be transposed onto chromosome #14, and that each 14q+ translocation in DHL represents an event that transposes an oncogene from another chromosome to chromosome #14.</div>
</front>
</TEI>
<istex>
<corpusName>elsevier</corpusName>
<keywords>
<teeft>
<json:string>chromosome</json:string>
<json:string>translocation</json:string>
<json:string>lymphoma</json:string>
<json:string>cell lines</json:string>
<json:string>histiocytic</json:string>
<json:string>cytogenetic</json:string>
<json:string>hecht</json:string>
<json:string>immunoglobulin</json:string>
<json:string>malignant</json:string>
<json:string>oncogene</json:string>
<json:string>rearrangement</json:string>
<json:string>chromosomal</json:string>
<json:string>abnormality</json:string>
<json:string>karyotype</json:string>
<json:string>lymphoma cell lines</json:string>
<json:string>lymphocytic</json:string>
<json:string>kaplan</json:string>
<json:string>large cell</json:string>
<json:string>proc natl acad</json:string>
<json:string>epstein</json:string>
<json:string>malignant lymphomas</json:string>
<json:string>intermediate grade</json:string>
<json:string>marker chromosome</json:string>
<json:string>human immunoglobulin</json:string>
<json:string>human chromosomes</json:string>
<json:string>diffuse histiocytic</json:string>
<json:string>cell line</json:string>
<json:string>malignant lymphoma</json:string>
<json:string>cell type</json:string>
<json:string>histiocytic lymphoma cell lines</json:string>
<json:string>cell lymphomas</json:string>
<json:string>large cell immunoblastic</json:string>
<json:string>null cell</json:string>
<json:string>biomedical research institute</json:string>
<json:string>cytogenetic studies</json:string>
<json:string>chain genes</json:string>
<json:string>leukemia</json:string>
<json:string>diffuse</json:string>
</teeft>
</keywords>
<author>
<json:item>
<name>Barbara Kaiser-McCaw Hecht</name>
<affiliations>
<json:string>Genetics Center and Cancer Research Center, Southwest Biomedical Research Institute, Tempe, AZ, USA</json:string>
</affiliations>
</json:item>
<json:item>
<name>Alan L. Epstein</name>
<affiliations>
<json:string>Department of Medicine, Northwestern University, Chicago, IL, USA</json:string>
</affiliations>
</json:item>
<json:item>
<name>Carol S. Berger</name>
<affiliations>
<json:string>Genetics Center and Cancer Research Center, Southwest Biomedical Research Institute, Tempe, AZ, USA</json:string>
</affiliations>
</json:item>
<json:item>
<name>Henry S. Kaplan</name>
<affiliations>
<json:string>Cancer Biology Research Laboratory, Stanford University School of Medicine, Stanford, CA, USA</json:string>
</affiliations>
</json:item>
<json:item>
<name>Frederick Hecht</name>
<affiliations>
<json:string>Genetics Center and Cancer Research Center, Southwest Biomedical Research Institute, Tempe, AZ, USA</json:string>
</affiliations>
</json:item>
</author>
<arkIstex>ark:/67375/6H6-2BQ8GRHQ-8</arkIstex>
<language>
<json:string>eng</json:string>
</language>
<originalGenre>
<json:string>Full-length article</json:string>
</originalGenre>
<abstract>Abstract: Cell lines were established from 15 patients with diffuse histiocytic lymphoma (DHL) of the intermediate grade, diffuse large cell (class G), and high-grade, large cell immunoblastic (class H) types. Immunologic studies indicated that 11 of the 15 DHL cell lines were B cell in origin, 2 were histiocytic, and 2 were null cell. Cytogenetic studies revealed 1 hypodiploid, 11 hyperdiploid, and 3 near-tetraploid cell lines. Chromosome #7 was trisomic in 3 lines, chromosomes #12 in 4 lines, and chromosome #13 in 3 lines. Chromosome #2 was monosomic in 3 lines, chromosome #8 was monosomic in 5 lines, chromosome #14 in 4 lines, and chromosome #22 in 6 cell lines. This is of special interest, as chromosomes #2, #8, #14, and #22 are clearly concerned with rearrangements in Burkitt's lymphoma and immunoglobulin expression. The most common rearrangement in the DHL cell lines involved chromosome #14 at band 14q32. However, in contrast to Burkitt's lymphoma, the pattern of translocation in DHL is between chromosome #14 and usually chromosome #11 or chromosome #18. The 14;18 translocation is not restricted to patients with low-grade follicular, small cleaved cell lymphomas, as has been reported. The 14q+ chromosome is characteristic of lymphoid malignancies in general. It is due, invariably, to a translocation with the breakpoint in band 14q32, which is the locus of the immunoglobulin heavy chain genes. We propose that in each translocation, for example, chromosomes #11 or #18, an oncogene may be transposed onto chromosome #14, and that each 14q+ translocation in DHL represents an event that transposes an oncogene from another chromosome to chromosome #14.</abstract>
<qualityIndicators>
<score>10</score>
<pdfWordCount>6711</pdfWordCount>
<pdfCharCount>28811</pdfCharCount>
<pdfVersion>1.4</pdfVersion>
<pdfPageCount>14</pdfPageCount>
<pdfPageSize>504 x 720 pts</pdfPageSize>
<refBibsNative>true</refBibsNative>
<abstractWordCount>263</abstractWordCount>
<abstractCharCount>1679</abstractCharCount>
<keywordCount>0</keywordCount>
</qualityIndicators>
<title>Histiocytic lymphoma cell lines: Immunologic and cytogenetic studies</title>
<pmid>
<json:string>3881165</json:string>
</pmid>
<pii>
<json:string>0165-4608(85)90186-4</json:string>
</pii>
<genre>
<json:string>research-article</json:string>
</genre>
<serie>
<title>Proc Natl Acad Sci USA</title>
<language>
<json:string>unknown</json:string>
</language>
<volume>72</volume>
<pages>
<first>2071</first>
<last>2075</last>
</pages>
</serie>
<host>
<title>Cancer Genetics and Cytogenetics</title>
<language>
<json:string>unknown</json:string>
</language>
<publicationDate>1985</publicationDate>
<issn>
<json:string>0165-4608</json:string>
</issn>
<pii>
<json:string>S0165-4608(00)X0188-4</json:string>
</pii>
<volume>14</volume>
<issue>3–4</issue>
<pages>
<first>205</first>
<last>218</last>
</pages>
<genre>
<json:string>journal</json:string>
</genre>
</host>
<namedEntities>
<unitex>
<date>
<json:string>1982</json:string>
<json:string>1984</json:string>
</date>
<geogName></geogName>
<orgName>
<json:string>Northwestern University</json:string>
<json:string>Elsevier Science Publishing Co.</json:string>
<json:string>Stanford University</json:string>
<json:string>Cancer Research Center, Southwest Biomedical Research Institute</json:string>
<json:string>American Burkitt</json:string>
<json:string>National Cancer Institute</json:string>
<json:string>Genetics Center</json:string>
<json:string>Department of Medicine</json:string>
<json:string>Cancer Biology Research Laboratory and the Department of Radiology, Stanford University School of Medicine, Stanford, CA</json:string>
<json:string>Leukemia Research Fund, the Carolyn and Lena</json:string>
<json:string>Cancer Center</json:string>
<json:string>National Institutes of Child Health and Human Development</json:string>
<json:string>East University</json:string>
<json:string>Research Grant HD-12601</json:string>
<json:string>Research Grants CA</json:string>
</orgName>
<orgName_funder>
<json:string>Research Grant HD-12601</json:string>
<json:string>Research Grants CA</json:string>
</orgName_funder>
<orgName_provider></orgName_provider>
<persName>
<json:string>Carol S. Berger</json:string>
<json:string>Alan L. Epstein</json:string>
<json:string>Diane Drupka</json:string>
<json:string>S. E. Villafane</json:string>
<json:string>Henry S. Kaplan</json:string>
<json:string>K. Overton</json:string>
<json:string>Barbara Kaiser-McCaw</json:string>
<json:string>Malcolm Hecht</json:string>
<json:string>Nancy Pleibel</json:string>
<json:string>B. Kaiser-McCaw</json:string>
<json:string>Joseph Edward</json:string>
<json:string>Jean Lee</json:string>
</persName>
<placeName>
<json:string>IL</json:string>
<json:string>NY</json:string>
<json:string>York</json:string>
</placeName>
<ref_url></ref_url>
<ref_bibl>
<json:string>[25, 30, 35-37]</json:string>
<json:string>[4]</json:string>
<json:string>[23]</json:string>
<json:string>[29]</json:string>
<json:string>[6]</json:string>
<json:string>[44-51]</json:string>
<json:string>[33]</json:string>
<json:string>[22-28, 30]</json:string>
<json:string>[39]</json:string>
<json:string>[1]</json:string>
<json:string>[43]</json:string>
<json:string>[38]</json:string>
<json:string>[3]</json:string>
<json:string>[42]</json:string>
<json:string>[4, 5]</json:string>
<json:string>[37]</json:string>
<json:string>[41]</json:string>
<json:string>Hecht et al.</json:string>
<json:string>[31, 32]</json:string>
<json:string>[40]</json:string>
<json:string>[2]</json:string>
<json:string>[7-14]</json:string>
<json:string>[21-28]</json:string>
</ref_bibl>
<bibl></bibl>
</unitex>
</namedEntities>
<ark>
<json:string>ark:/67375/6H6-2BQ8GRHQ-8</json:string>
</ark>
<categories>
<wos></wos>
<scienceMetrix>
<json:string>1 - health sciences</json:string>
<json:string>2 - clinical medicine</json:string>
<json:string>3 - oncology & carcinogenesis</json:string>
</scienceMetrix>
<scopus>
<json:string>1 - Life Sciences</json:string>
<json:string>2 - Biochemistry, Genetics and Molecular Biology</json:string>
<json:string>3 - Cancer Research</json:string>
<json:string>1 - Life Sciences</json:string>
<json:string>2 - Biochemistry, Genetics and Molecular Biology</json:string>
<json:string>3 - Genetics</json:string>
<json:string>1 - Life Sciences</json:string>
<json:string>2 - Biochemistry, Genetics and Molecular Biology</json:string>
<json:string>3 - Molecular Biology</json:string>
</scopus>
<inist>
<json:string>1 - sciences appliquees, technologies et medecines</json:string>
<json:string>2 - sciences biologiques et medicales</json:string>
<json:string>3 - sciences medicales</json:string>
<json:string>4 - hemopathies</json:string>
</inist>
</categories>
<publicationDate>1984</publicationDate>
<copyrightDate>1984</copyrightDate>
<doi>
<json:string>10.1016/0165-4608(85)90186-4</json:string>
</doi>
<id>6473D2AA67B2D7B908E7412174A4A224DBE56489</id>
<score>1</score>
<fulltext>
<json:item>
<extension>pdf</extension>
<original>true</original>
<mimetype>application/pdf</mimetype>
<uri>https://api.istex.fr/document/6473D2AA67B2D7B908E7412174A4A224DBE56489/fulltext/pdf</uri>
</json:item>
<json:item>
<extension>zip</extension>
<original>false</original>
<mimetype>application/zip</mimetype>
<uri>https://api.istex.fr/document/6473D2AA67B2D7B908E7412174A4A224DBE56489/fulltext/zip</uri>
</json:item>
<istex:fulltextTEI uri="https://api.istex.fr/document/6473D2AA67B2D7B908E7412174A4A224DBE56489/fulltext/tei">
<teiHeader>
<fileDesc>
<titleStmt>
<title level="a">Histiocytic lymphoma cell lines: Immunologic and cytogenetic studies</title>
</titleStmt>
<publicationStmt>
<authority>ISTEX</authority>
<publisher>ELSEVIER</publisher>
<availability>
<p>ELSEVIER</p>
</availability>
<date>1984</date>
</publicationStmt>
<notesStmt>
<note>This work was supported in part by Research Grants CA-25055 and RO1-CA 30621 and Contract NO1-CP-43228 from the National Cancer Institute; Research Grant HD-12601 from the National Institutes of Child Health and Human Development; and by gifts to the Malcolm Hecht, Jr., Leukemia Research Fund, the Carolyn and Lena Kaiser Cancer Research Fund, and the Joseph Edward Luetje Lymphoma Research Fund.</note>
</notesStmt>
<sourceDesc>
<biblStruct type="inbook">
<analytic>
<title level="a">Histiocytic lymphoma cell lines: Immunologic and cytogenetic studies</title>
<author xml:id="author-0000">
<persName>
<forename type="first">Barbara Kaiser-McCaw</forename>
<surname>Hecht</surname>
</persName>
<note type="biography">Address requests for reprints to Dr. Barbara Kaiser-McCaw Hecht, Genetics Center and Cancer Research Center, Southwest Biomedical Research Institute, 123 East University Drive, Tempe, AZ 85281.</note>
<affiliation>Address requests for reprints to Dr. Barbara Kaiser-McCaw Hecht, Genetics Center and Cancer Research Center, Southwest Biomedical Research Institute, 123 East University Drive, Tempe, AZ 85281.</affiliation>
<affiliation>Genetics Center and Cancer Research Center, Southwest Biomedical Research Institute, Tempe, AZ, USA</affiliation>
</author>
<author xml:id="author-0001">
<persName>
<forename type="first">Alan L.</forename>
<surname>Epstein</surname>
</persName>
<affiliation>Department of Medicine, Northwestern University, Chicago, IL, USA</affiliation>
</author>
<author xml:id="author-0002">
<persName>
<forename type="first">Carol S.</forename>
<surname>Berger</surname>
</persName>
<affiliation>Genetics Center and Cancer Research Center, Southwest Biomedical Research Institute, Tempe, AZ, USA</affiliation>
</author>
<author xml:id="author-0003">
<persName>
<forename type="first">Henry S.</forename>
<surname>Kaplan</surname>
</persName>
<affiliation>Cancer Biology Research Laboratory, Stanford University School of Medicine, Stanford, CA, USA</affiliation>
</author>
<author xml:id="author-0004">
<persName>
<forename type="first">Frederick</forename>
<surname>Hecht</surname>
</persName>
<affiliation>Genetics Center and Cancer Research Center, Southwest Biomedical Research Institute, Tempe, AZ, USA</affiliation>
</author>
<idno type="istex">6473D2AA67B2D7B908E7412174A4A224DBE56489</idno>
<idno type="DOI">10.1016/0165-4608(85)90186-4</idno>
<idno type="PII">0165-4608(85)90186-4</idno>
</analytic>
<monogr>
<title level="j">Cancer Genetics and Cytogenetics</title>
<title level="j" type="abbrev">CGC</title>
<idno type="pISSN">0165-4608</idno>
<idno type="PII">S0165-4608(00)X0188-4</idno>
<imprint>
<publisher>ELSEVIER</publisher>
<date type="published" when="1984"></date>
<biblScope unit="volume">14</biblScope>
<biblScope unit="issue">3–4</biblScope>
<biblScope unit="page" from="205">205</biblScope>
<biblScope unit="page" to="218">218</biblScope>
</imprint>
</monogr>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc>
<creation>
<date>1984</date>
</creation>
<langUsage>
<language ident="en">en</language>
</langUsage>
<abstract xml:lang="en">
<p>Cell lines were established from 15 patients with diffuse histiocytic lymphoma (DHL) of the intermediate grade, diffuse large cell (class G), and high-grade, large cell immunoblastic (class H) types. Immunologic studies indicated that 11 of the 15 DHL cell lines were B cell in origin, 2 were histiocytic, and 2 were null cell. Cytogenetic studies revealed 1 hypodiploid, 11 hyperdiploid, and 3 near-tetraploid cell lines. Chromosome #7 was trisomic in 3 lines, chromosomes #12 in 4 lines, and chromosome #13 in 3 lines. Chromosome #2 was monosomic in 3 lines, chromosome #8 was monosomic in 5 lines, chromosome #14 in 4 lines, and chromosome #22 in 6 cell lines. This is of special interest, as chromosomes #2, #8, #14, and #22 are clearly concerned with rearrangements in Burkitt's lymphoma and immunoglobulin expression. The most common rearrangement in the DHL cell lines involved chromosome #14 at band 14q32. However, in contrast to Burkitt's lymphoma, the pattern of translocation in DHL is between chromosome #14 and usually chromosome #11 or chromosome #18. The 14;18 translocation is not restricted to patients with low-grade follicular, small cleaved cell lymphomas, as has been reported. The 14q+ chromosome is characteristic of lymphoid malignancies in general. It is due, invariably, to a translocation with the breakpoint in band 14q32, which is the locus of the immunoglobulin heavy chain genes. We propose that in each translocation, for example, chromosomes #11 or #18, an oncogene may be transposed onto chromosome #14, and that each 14q+ translocation in DHL represents an event that transposes an oncogene from another chromosome to chromosome #14.</p>
</abstract>
</profileDesc>
<revisionDesc>
<change when="1984">Published</change>
</revisionDesc>
</teiHeader>
</istex:fulltextTEI>
<json:item>
<extension>txt</extension>
<original>false</original>
<mimetype>text/plain</mimetype>
<uri>https://api.istex.fr/document/6473D2AA67B2D7B908E7412174A4A224DBE56489/fulltext/txt</uri>
</json:item>
</fulltext>
<metadata>
<istex:metadataXml wicri:clean="Elsevier, elements deleted: tail">
<istex:xmlDeclaration>version="1.0" encoding="utf-8"</istex:xmlDeclaration>
<istex:docType PUBLIC="-//ES//DTD journal article DTD version 4.5.2//EN//XML" URI="art452.dtd" name="istex:docType"></istex:docType>
<istex:document>
<converted-article version="4.5.2" docsubtype="fla">
<item-info>
<jid>CGC</jid>
<aid>85901864</aid>
<ce:pii>0165-4608(85)90186-4</ce:pii>
<ce:doi>10.1016/0165-4608(85)90186-4</ce:doi>
<ce:copyright type="unknown" year="1984"></ce:copyright>
</item-info>
<head>
<ce:article-footnote>
<ce:label></ce:label>
<ce:note-para>This work was supported in part by Research Grants CA-25055 and RO1-CA 30621 and Contract NO1-CP-43228 from the National Cancer Institute; Research Grant HD-12601 from the National Institutes of Child Health and Human Development; and by gifts to the Malcolm Hecht, Jr., Leukemia Research Fund, the Carolyn and Lena Kaiser Cancer Research Fund, and the Joseph Edward Luetje Lymphoma Research Fund.</ce:note-para>
</ce:article-footnote>
<ce:title>Histiocytic lymphoma cell lines: Immunologic and cytogenetic studies</ce:title>
<ce:author-group>
<ce:author>
<ce:given-name>Barbara Kaiser-McCaw</ce:given-name>
<ce:surname>Hecht</ce:surname>
<ce:cross-ref refid="COR1">
<ce:sup></ce:sup>
</ce:cross-ref>
<ce:cross-ref refid="AFF1">
<ce:sup>a</ce:sup>
</ce:cross-ref>
</ce:author>
<ce:author>
<ce:given-name>Alan L.</ce:given-name>
<ce:surname>Epstein</ce:surname>
<ce:cross-ref refid="AFF2">
<ce:sup>b</ce:sup>
</ce:cross-ref>
<ce:cross-ref refid="AFF3">
<ce:sup>c</ce:sup>
</ce:cross-ref>
</ce:author>
<ce:author>
<ce:given-name>Carol S.</ce:given-name>
<ce:surname>Berger</ce:surname>
<ce:cross-ref refid="AFF1">
<ce:sup>a</ce:sup>
</ce:cross-ref>
</ce:author>
<ce:author>
<ce:given-name>Henry S.</ce:given-name>
<ce:surname>Kaplan</ce:surname>
<ce:cross-ref refid="AFF4">
<ce:sup>d</ce:sup>
</ce:cross-ref>
<ce:cross-ref refid="AFF5">
<ce:sup>e</ce:sup>
</ce:cross-ref>
</ce:author>
<ce:author>
<ce:given-name>Frederick</ce:given-name>
<ce:surname>Hecht</ce:surname>
<ce:cross-ref refid="AFF1">
<ce:sup>a</ce:sup>
</ce:cross-ref>
</ce:author>
<ce:affiliation id="AFF1">
<ce:label>a</ce:label>
<ce:textfn>Genetics Center and Cancer Research Center, Southwest Biomedical Research Institute, Tempe, AZ, USA</ce:textfn>
</ce:affiliation>
<ce:affiliation id="AFF2">
<ce:label>b</ce:label>
<ce:textfn>Department of Medicine, Northwestern University, Chicago, IL, USA</ce:textfn>
</ce:affiliation>
<ce:affiliation id="AFF3">
<ce:label>c</ce:label>
<ce:textfn>Cancer Center, Northwestern University, Chicago, IL, USA</ce:textfn>
</ce:affiliation>
<ce:affiliation id="AFF4">
<ce:label>d</ce:label>
<ce:textfn>Cancer Biology Research Laboratory, Stanford University School of Medicine, Stanford, CA, USA</ce:textfn>
</ce:affiliation>
<ce:affiliation id="AFF5">
<ce:label>e</ce:label>
<ce:textfn>Department of Radiology, Stanford University School of Medicine, Stanford, CA, USA</ce:textfn>
</ce:affiliation>
<ce:correspondence id="COR1">
<ce:label></ce:label>
<ce:text>Address requests for reprints to Dr. Barbara Kaiser-McCaw Hecht, Genetics Center and Cancer Research Center, Southwest Biomedical Research Institute, 123 East University Drive, Tempe, AZ 85281.</ce:text>
</ce:correspondence>
</ce:author-group>
<ce:date-received day="20" month="7" year="1983"></ce:date-received>
<ce:date-accepted day="21" month="12" year="1983"></ce:date-accepted>
<ce:abstract>
<ce:section-title>Abstract</ce:section-title>
<ce:abstract-sec>
<ce:simple-para>Cell lines were established from 15 patients with diffuse histiocytic lymphoma (DHL) of the intermediate grade, diffuse large cell (class G), and high-grade, large cell immunoblastic (class H) types. Immunologic studies indicated that 11 of the 15 DHL cell lines were B cell in origin, 2 were histiocytic, and 2 were null cell. Cytogenetic studies revealed 1 hypodiploid, 11 hyperdiploid, and 3 near-tetraploid cell lines. Chromosome #7 was trisomic in 3 lines, chromosomes #12 in 4 lines, and chromosome #13 in 3 lines. Chromosome #2 was monosomic in 3 lines, chromosome #8 was monosomic in 5 lines, chromosome #14 in 4 lines, and chromosome #22 in 6 cell lines. This is of special interest, as chromosomes #2, #8, #14, and #22 are clearly concerned with rearrangements in Burkitt's lymphoma and immunoglobulin expression. The most common rearrangement in the DHL cell lines involved chromosome #14 at band 14q32. However, in contrast to Burkitt's lymphoma, the pattern of translocation in DHL is between chromosome #14 and usually chromosome #11 or chromosome #18. The 14;18 translocation is not restricted to patients with low-grade follicular, small cleaved cell lymphomas, as has been reported. The 14q+ chromosome is characteristic of lymphoid malignancies in general. It is due, invariably, to a translocation with the breakpoint in band 14q32, which is the locus of the immunoglobulin heavy chain genes. We propose that in each translocation, for example, chromosomes #11 or #18, an oncogene may be transposed onto chromosome #14, and that each 14q+ translocation in DHL represents an event that transposes an oncogene from another chromosome to chromosome #14.</ce:simple-para>
</ce:abstract-sec>
</ce:abstract>
</head>
</converted-article>
</istex:document>
</istex:metadataXml>
<mods version="3.6">
<titleInfo>
<title>Histiocytic lymphoma cell lines: Immunologic and cytogenetic studies</title>
</titleInfo>
<titleInfo type="alternative" contentType="CDATA">
<title>Histiocytic lymphoma cell lines: Immunologic and cytogenetic studies</title>
</titleInfo>
<name type="personal">
<namePart type="given">Barbara Kaiser-McCaw</namePart>
<namePart type="family">Hecht</namePart>
<affiliation>Genetics Center and Cancer Research Center, Southwest Biomedical Research Institute, Tempe, AZ, USA</affiliation>
<description>Address requests for reprints to Dr. Barbara Kaiser-McCaw Hecht, Genetics Center and Cancer Research Center, Southwest Biomedical Research Institute, 123 East University Drive, Tempe, AZ 85281.</description>
<role>
<roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal">
<namePart type="given">Alan L.</namePart>
<namePart type="family">Epstein</namePart>
<affiliation>Department of Medicine, Northwestern University, Chicago, IL, USA</affiliation>
<role>
<roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal">
<namePart type="given">Carol S.</namePart>
<namePart type="family">Berger</namePart>
<affiliation>Genetics Center and Cancer Research Center, Southwest Biomedical Research Institute, Tempe, AZ, USA</affiliation>
<role>
<roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal">
<namePart type="given">Henry S.</namePart>
<namePart type="family">Kaplan</namePart>
<affiliation>Cancer Biology Research Laboratory, Stanford University School of Medicine, Stanford, CA, USA</affiliation>
<role>
<roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal">
<namePart type="given">Frederick</namePart>
<namePart type="family">Hecht</namePart>
<affiliation>Genetics Center and Cancer Research Center, Southwest Biomedical Research Institute, Tempe, AZ, USA</affiliation>
<role>
<roleTerm type="text">author</roleTerm>
</role>
</name>
<typeOfResource>text</typeOfResource>
<genre type="research-article" displayLabel="Full-length article" authority="ISTEX" authorityURI="https://content-type.data.istex.fr" valueURI="https://content-type.data.istex.fr/ark:/67375/XTP-1JC4F85T-7">research-article</genre>
<originInfo>
<publisher>ELSEVIER</publisher>
<dateIssued encoding="w3cdtf">1984</dateIssued>
<copyrightDate encoding="w3cdtf">1984</copyrightDate>
</originInfo>
<language>
<languageTerm type="code" authority="iso639-2b">eng</languageTerm>
<languageTerm type="code" authority="rfc3066">en</languageTerm>
</language>
<abstract lang="en">Abstract: Cell lines were established from 15 patients with diffuse histiocytic lymphoma (DHL) of the intermediate grade, diffuse large cell (class G), and high-grade, large cell immunoblastic (class H) types. Immunologic studies indicated that 11 of the 15 DHL cell lines were B cell in origin, 2 were histiocytic, and 2 were null cell. Cytogenetic studies revealed 1 hypodiploid, 11 hyperdiploid, and 3 near-tetraploid cell lines. Chromosome #7 was trisomic in 3 lines, chromosomes #12 in 4 lines, and chromosome #13 in 3 lines. Chromosome #2 was monosomic in 3 lines, chromosome #8 was monosomic in 5 lines, chromosome #14 in 4 lines, and chromosome #22 in 6 cell lines. This is of special interest, as chromosomes #2, #8, #14, and #22 are clearly concerned with rearrangements in Burkitt's lymphoma and immunoglobulin expression. The most common rearrangement in the DHL cell lines involved chromosome #14 at band 14q32. However, in contrast to Burkitt's lymphoma, the pattern of translocation in DHL is between chromosome #14 and usually chromosome #11 or chromosome #18. The 14;18 translocation is not restricted to patients with low-grade follicular, small cleaved cell lymphomas, as has been reported. The 14q+ chromosome is characteristic of lymphoid malignancies in general. It is due, invariably, to a translocation with the breakpoint in band 14q32, which is the locus of the immunoglobulin heavy chain genes. We propose that in each translocation, for example, chromosomes #11 or #18, an oncogene may be transposed onto chromosome #14, and that each 14q+ translocation in DHL represents an event that transposes an oncogene from another chromosome to chromosome #14.</abstract>
<note>This work was supported in part by Research Grants CA-25055 and RO1-CA 30621 and Contract NO1-CP-43228 from the National Cancer Institute; Research Grant HD-12601 from the National Institutes of Child Health and Human Development; and by gifts to the Malcolm Hecht, Jr., Leukemia Research Fund, the Carolyn and Lena Kaiser Cancer Research Fund, and the Joseph Edward Luetje Lymphoma Research Fund.</note>
<relatedItem type="host">
<titleInfo>
<title>Cancer Genetics and Cytogenetics</title>
</titleInfo>
<titleInfo type="abbreviated">
<title>CGC</title>
</titleInfo>
<genre type="journal" authority="ISTEX" authorityURI="https://publication-type.data.istex.fr" valueURI="https://publication-type.data.istex.fr/ark:/67375/JMC-0GLKJH51-B">journal</genre>
<originInfo>
<publisher>ELSEVIER</publisher>
<dateIssued encoding="w3cdtf">19850115</dateIssued>
</originInfo>
<identifier type="ISSN">0165-4608</identifier>
<identifier type="PII">S0165-4608(00)X0188-4</identifier>
<part>
<date>19850115</date>
<detail type="volume">
<number>14</number>
<caption>vol.</caption>
</detail>
<detail type="issue">
<number>3–4</number>
<caption>no.</caption>
</detail>
<extent unit="issue-pages">
<start>191</start>
<end>375</end>
</extent>
<extent unit="pages">
<start>205</start>
<end>218</end>
</extent>
</part>
</relatedItem>
<identifier type="istex">6473D2AA67B2D7B908E7412174A4A224DBE56489</identifier>
<identifier type="ark">ark:/67375/6H6-2BQ8GRHQ-8</identifier>
<identifier type="DOI">10.1016/0165-4608(85)90186-4</identifier>
<identifier type="PII">0165-4608(85)90186-4</identifier>
<recordInfo>
<recordContentSource authority="ISTEX" authorityURI="https://loaded-corpus.data.istex.fr" valueURI="https://loaded-corpus.data.istex.fr/ark:/67375/XBH-HKKZVM7B-M">elsevier</recordContentSource>
</recordInfo>
</mods>
<json:item>
<extension>json</extension>
<original>false</original>
<mimetype>application/json</mimetype>
<uri>https://api.istex.fr/document/6473D2AA67B2D7B908E7412174A4A224DBE56489/metadata/json</uri>
</json:item>
</metadata>
</istex>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Psychologie/explor/BernheimV1/Data/Istex/Corpus
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000874 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/Istex/Corpus/biblio.hfd -nk 000874 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Psychologie
   |area=    BernheimV1
   |flux=    Istex
   |étape=   Corpus
   |type=    RBID
   |clé=     ISTEX:6473D2AA67B2D7B908E7412174A4A224DBE56489
   |texte=   Histiocytic lymphoma cell lines: Immunologic and cytogenetic studies
}}

Wicri

This area was generated with Dilib version V0.6.33.
Data generation: Mon Mar 5 17:33:33 2018. Site generation: Thu Apr 29 15:49:51 2021